Israel’s BiolineRx has reported positive results from Phase II trials of its BL-8040 treatment in relapsed or refractory acute myeloid leukemia and researchers at the Hebrew University of Jerusalem have uncovered a key gene responsible for ovary development.

Israel is part of an international team working on creating a digital reconstruction of the brain, and Weizmann Institute Professor Michal Schwartz was featured in Good Housekeeping magazine in an article that explains how the brain and the immune system communicate.